Drug Profile
IN 10 003
Alternative Names: IN10003Latest Information Update: 09 Aug 2021
Price :
$50
*
At a glance
- Originator Intec Pharma
- Class Sleep disorder therapies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Insomnia
Most Recent Events
- 03 Aug 2021 Decoy Biosystems has merged with Intec Pharma to form Indaptus Therapeutics